These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31931152)

  • 1. Regulation of immune-driven pathogenesis in Parkinson's disease by gut microbiota.
    Zheng W; He R; Yan Z; Huang Y; Huang W; Cai Z; Su Y; Liu S; Deng Y; Wang Q; Xie H
    Brain Behav Immun; 2020 Jul; 87():890-897. PubMed ID: 31931152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New hope for Parkinson's disease treatment: Targeting gut microbiota.
    Fan HX; Sheng S; Zhang F
    CNS Neurosci Ther; 2022 Nov; 28(11):1675-1688. PubMed ID: 35822696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease.
    Campos-Acuña J; Elgueta D; Pacheco R
    Front Immunol; 2019; 10():239. PubMed ID: 30828335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of the gut microbiota in Parkinson's disease].
    Verugina NI; Levin OS; Lyashenko EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(10. Vyp. 2):86-91. PubMed ID: 34870920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain-gut-microbiota axis in Parkinson's disease.
    Mulak A; Bonaz B
    World J Gastroenterol; 2015 Oct; 21(37):10609-20. PubMed ID: 26457021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
    Caputi V; Giron MC
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of the neuroendocrine system in Parkinson's disease: what is the impact on diagnosis and treatment?
    Mulak A
    Expert Rev Neurother; 2020 Feb; 20(2):127-135. PubMed ID: 31829756
    [No Abstract]   [Full Text] [Related]  

  • 8. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease.
    Lin CH; Chen CC; Chiang HL; Liou JM; Chang CM; Lu TP; Chuang EY; Tai YC; Cheng C; Lin HY; Wu MS
    J Neuroinflammation; 2019 Jun; 16(1):129. PubMed ID: 31248424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The gut microbiome in Parkinson's disease: A culprit or a bystander?
    Keshavarzian A; Engen P; Bonvegna S; Cilia R
    Prog Brain Res; 2020; 252():357-450. PubMed ID: 32247371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unravelling the role of gut microbiota in Parkinson's disease progression: Pathogenic and therapeutic implications.
    Rani L; Mondal AC
    Neurosci Res; 2021 Jul; 168():100-112. PubMed ID: 33417973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease.
    Lai F; Jiang R; Xie W; Liu X; Tang Y; Xiao H; Gao J; Jia Y; Bai Q
    Neurochem Res; 2018 Oct; 43(10):1986-1999. PubMed ID: 30171422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A role of the gastrointestinal tract microbiota in the pathogenesis of Parkinson's disease].
    Alifirova VM; Zhukova NG; Zhukova IA; Latypova AV; Titova MA; Mironova YS; Izhboldina OP; Nikitina MA; Petrov VA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11):174-179. PubMed ID: 28635757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota differences between healthy older adults and individuals with Parkinson's disease: A systematic review.
    Nuzum ND; Loughman A; Szymlek-Gay EA; Hendy A; Teo WP; Macpherson H
    Neurosci Biobehav Rev; 2020 May; 112():227-241. PubMed ID: 32032654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of The Gut Microbiome in Parkinson's Disease.
    Gallop A; Weagley J; Paracha SU; Grossberg G
    J Geriatr Psychiatry Neurol; 2021 Jul; 34(4):253-262. PubMed ID: 34219519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Avenues for Parkinson's Disease Therapeutics: Disease-Modifying Strategies Based on the Gut Microbiota.
    Lorente-Picón M; Laguna A
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33804226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential role of gut microbiota and tissue barriers in Parkinson's disease and amyotrophic lateral sclerosis.
    Fang X
    Int J Neurosci; 2016 Sep; 126(9):771-6. PubMed ID: 26381230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advances in fecal microbiota transplantation for treatment of Parkinson's disease].
    Zhang M; Wang H; Xue L; Yang X
    Sheng Wu Gong Cheng Xue Bao; 2021 Nov; 37(11):3812-3819. PubMed ID: 34841786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The gut microbiome in Parkinson's disease].
    Bedarf JR; Hildebrand F; Goeser F; Bork P; Wüllner U
    Nervenarzt; 2019 Feb; 90(2):160-166. PubMed ID: 30171304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway.
    Sun MF; Zhu YL; Zhou ZL; Jia XB; Xu YD; Yang Q; Cui C; Shen YQ
    Brain Behav Immun; 2018 May; 70():48-60. PubMed ID: 29471030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
    Sun MF; Shen YQ
    Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.